J Herbmed Pharmacol. 2021; 10(1): 75-83.
http://www.herbmedpharmacol.com
doi: 10.34172/jhp.2021.07
Journal of Herbmed Pharmacology
Quantitative screening of phytochemicals and pharmacological
attributions of the leaves and stem barks of Macropanax
dispermus (Araliaceae) in treating the inflammation and
arthritis
Syeda Rubaiya Afrin ID , Mohammad Rashedul Islam ID , Nawreen Monir Proma ID , Mahabuba Khanam Shorna ID ,
Sumaiya Akbar ID , Mohammed Kamrul Hossain ID *
Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong-4331, Bangladesh
ARTICLE INFO
ABSTRACT
Article Type:
Introduction: Inflammation is a major cause of arthritis. Since the conventional medicines
used for the treatment of this disease have many side effects, herbal remedies can be proved
to be effective in this case. So, the present study was aimed at investigating the quantitative
detection of phytochemicals, screening of in vivo anti-inflammatory and the possible antiarthritic activities of the crude methanol extracts of a traditional medicinal plant Macropanax
dispermus leaves (MDML) and stem barks (MDMS).
Methods: Quantitative screening of phytochemical constituents was analyzed by standard
procedures. The in vivo anti-inflammatory activity was conducted on Swiss albino mice by
using carrageenan and formalin-induced paw edema tests, and xylene-induced ear edema
test. The possible anti-arthritic activity was done by evaluating the in vitro inhibition of
bovine serum albumin (BSA) denaturation.
Results: The current research showed that MDML contained a considerable amount of
flavonoids and alkaloids, and MDMS contained a considerable amount of phenols. MDMS
(200, 400 mg/kg) was observed to be an effective and significant (P < 0.001) peripheral antiinflammatory agent in carrageenan and formalin-induced paw edema tests, whereas MDML
(400 mg/kg) was observed to have an effective and significant (P < 0.001) neurogenic antiinflammatory effect in xylene-induced ear edema test as compared to negative control group.
MDMS was observed to be an effective anti-arthritic agent as compared to that of negative
control group. All those effects were dose and concentration-dependent.
Conclusion: The present research proved that MDML and MDMS were effective medications
for the treatment of inflammation and arthritis.
Original Article
Article History:
Received: 4 January 2020
Accepted: 5 June 2020
Keywords:
Macropanax dispermus
Phytochemicals
Total flavonoid content
Anti-inflammatory activity
Anti-arthritis
Implication for health policy/practice/research/medical education:
The investigated Macropanax dispermus (Araliaceae) extract exhibited significant activity against inflammation and arthritis
and might contribute to formulate alternative medicinal agent to treat inflammatory disorders.
Please cite this paper as: Afrin SR, Islam MR, Proma NM, Shorna MK, Akbar S, Hossain MK. Quantitative screening of
phytochemicals and pharmacological attributions of the leaves and stem barks of Macropanax dispermus (Araliaceae) in treating
the inflammation and arthritis. J Herbmed Pharmacol. 2021;10(1):75-83. doi: 10.34172/jhp.2021.07.
Introduction
Inflammation is a reaction of the body against noxious
stimuli, characterized by vasodilatation, access of fluid
and cells to the target tissue (1). It is also characterized by
the increase in vascular permeability and mediator release
(2), an increase of protein denaturation and membrane
alteration (3). Further, leucocyte infiltration, edema and
granuloma formation demonstrate common features of
*Corresponding author: Mohammed Kamrul Hossain,
Email: mkhossain73@yahoo.com
inflammation (4).
Arthritis is one of the most common chronic
inflammatory disorders, a systemic autoimmune disease
and the prime cause of disability worldwide. Arthritis
causes the breakdown of cartilage that results in the
friction of bones together. It causes pain, swelling and
stiffness of joints of bones (5). It can be treated by using
drugs such as non-steroidal anti-inflammatory drugs
Afrin et al
(NSAIDs), corticosteroids, immunosuppressants, diseasemodifying anti-rheumatic drugs (DMARDs) and newer
biological agents such as tumor necrosis factor alpha
(TNFα) and monoclonal antibodies. But, those drugs have
severe side effects such as stomach irritation, malfunction
of the kidney, urticaria, liver disorders, hematological
abnormalities and gastrointestinal problems including
ulcers, bleeding, heartburn, diarrhea, retention of fluid
and perforation of stomach or intestine (6,7). Due to
the chronic nature of arthritis and adverse reactions
of NSAIDs and DMARDs, the advanced aged arthritic
patients tend to rely on alternative treatments that are
effective, less toxic and reduce the load of taking regular
multiple medicines.
Moreover, synthetic drugs are very costly to develop.
One drug requires approximately 3000-4000 compounds
to be synthesized, screened and tested whose cost ranges
from 0.5 to 5 million dollars. Hence, herbal drugs are
favored over conventional medicines by patients as they
have diminished the manifestations of illness and raised
the worth of life (8).
Macropanax dispermus is a medicinal tree from
the family of Araliaceae which is commonly found in
evergreen forested areas. It is traditionally used for the
treatment of indigestion, cough, menopausal fever,
malarial fever, postpartum bathing, elimination of waste
matter, and improvement of blood flow by ethnic people
of Thailand, Myanmar (9, 10). In the previous researches,
it was evident that its crude methanol extracts had a good
amount of vitamin E, carotene, xanthophylls, tannins,
phenolics and high amount of vitamin C (11).
Considering its medicinal properties, the leaves and
stem barks of this plant were selected to conduct the
investigations regarding the quantitative analysis of
phytochemicals, anti-inflammatory and anti-arthritic
properties of crude methanol extracts of M. dispermus
leaves (MDML) and stem barks (MDMS) to establish an
effective medicinal agent.
Materials and Methods
Chemicals
Methanol, gallic acid, quercetin, carrageenan, formalin,
xylene, bovine serum albumin (BSA), and other
chemicals used for the extraction, in vivo, and in vitro
pharmacological tests were laboratory grade (Merck,
Germany).
Collection and identification of the plant
The matured plant leaves and stem barks were collected
in August 2018 from the Rangamati district (Chattogram
hill tracts), Chattogram division of Bangladesh with the
help of a famous local traditional healer. Then, it was
distinguished as M. dispermus by a renowned taxonomist
of Bangladesh, Dr. Shaikh Bokhtear Uddin, Professor,
Department of Botany, University of Chittagong,
76
Bangladesh. A specimen was deposited there under the
herbarium no- sr20385.
Preparation of crude extracts
Plant materials (leaves and stem barks) were washed,
chopped into small pieces, and semi-shed sun-dried for
seven days. After drying, the plant materials were ground
with a mechanical grinder facilitated by Pharmacological
Research Laboratory, Department of Pharmacy, University
of Chittagong, Bangladesh. Ground portions of the leaves
(1.36 kg) and stem barks (493 g) of M. dispermus were
soaked in 7.29 L and 2.60 L of methanol, respectively. After
13 days of occasional shaking, the solution was filtered
and the filtrate was concentrated by evaporation method
under reduced pressure by using a rotary evaporator
(Stuart, UK) in the Pharmacological Research Laboratory,
Department of Pharmacy, University of Chittagong,
Bangladesh. The weight of the crude methanol extracts of
M. dispermus leaves and stem barks was 28.50 g. and 7.66
g., respectively. The percentage (%) yield of the extract
was calculated using the following equation (12):
% of yield of extract = (Weight of extract/ Weight of
powder) × 100
The percentage of yield of crude methanol extracts of M.
dispermus leaves and stem barks was 2.09% and 1.55%,
respectively.
Experimental animals
Male and female Swiss albino mice weighing approximately
20-30 g were used for experimental purposes. All the
animals were purchased from the animal house of
Jahangirnagar University, Bangladesh. The mice were
provided with nutritionally adequate diets (bought from
the aforementioned animal house) and drinking water ad
libitum throughout the study.
Study design
All the investigated extracts were used at the dose of 200
and 400 mg/kg of body weight of mice for the treatment
group, whereas 1% tween-80 at 10 mL/kg was used for
the negative control group. Indomethacin (10 mg/kg)
served as a positive control in carrageenan- and formalininduced paw edema tests. Prednisolone (10 mg/kg) served
as a positive control in xylene-induced ear edema test.
Quantitative phytochemical screening
Determination of total phenol content
Total phenol content in MDML and MDMS was
determined by using a previously described method
with little modification (13). A volume of 1 mL of each
of the extracts (1 mg/mL) was mixed with 5 mL of 10%
Folin-Ciocalteu solution and 5 mL of Na2CO3 (7.5%
w/v) solution. This mixture was vortexed for 15 sec and
incubated at 25°C for 20 minutes for color development.
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
http://www.herbmedpharmacol.com
In vivo and in vitro pharmacological investigations of Macropanax dispermus (Araliaceae)
The absorbance of total phenol was taken at 760 nm using
UV-Vis spectroscopy. To quantify total phenol content,
the gallic acid standard curve was prepared and the results
were displayed as milligrams of gallic acid equivalents
(GAE)/g of dried extract. The concentration of total
phenol content in the sample was determined by using the
following equation:
A=
c×v
m
Here, A= Total phenol content (mg/g gallic acid
equivalent), c= Concentration of gallic acid in mg/mL, v=
Volume of the extract (mL), m= Mass of the extract (g)
mice (16). Six groups of mice (five mice to each group)
were administered 1% tween-80 at 10 mL/kg, MDML
and MDMS at the dose of 200 & 400 mg/kg orally and
indomethacin at the dose of 10 mg/kg intraperitoneally.
One hour after the extracts and thirty minutes after
positive control administration, 100 µL of carrageenan (1%
w/v in 0.9% normal saline) was injected subcutaneously
into the right hind paw. Paw circumference was measured
through a digital vernier caliper before the injection of
carrageenan and thereafter at 1, 2, 3, and 4 hours. Paw
edema was expressed as the change in paw circumference
(mm) by using the following formula (1):
Inhibition of edema (%) =
Determination of total flavonoid content
Total flavonoids were determined using a previously
described method with minor modification on the
formation of a complex flavonoid-aluminum (14). One
milliliter of 2% aluminium chloride-ethanol solution
was mixed with 1 mL of each of the extracts (1 mg/mL).
The mixture was incubated for 1 hour for yellow color
development which indicated the presence of flavonoid.
The absorbance was measured at 420 nm by using a
UV-VIS spectrophotometer. To quantify total flavonoid
content, quercetin standard curve was used and the
results were expressed as quercetin equivalents (QE). The
concentration of total flavonoid content in the sample was
determined by using the following equation:
c×v
m
Here, A= Total flavonoid content (mg/g quercetin
equivalent), c= Concentration of quercetin in mg/mL, v=
Volume of the extract (mL), m= Mass of the extract (g)
A=
Determination of alkaloid content
Alkaloids were quantitatively determined according to the
previously described method with minor modifications
(15). Ten milliliters of 10% acetic acid in ethanol was
added to 0.25 g of each of the extracts, covered and allowed
to stand for 4 hours. The filtrate was then concentrated
on a water bath. Concentrated ammonium hydroxide was
added slowly to the extract until the precipitation was
accomplished. The collected precipitates were washed
with dilute ammonium hydroxide and then filtered. The
residue was dried and weighed. The alkaloid content was
determined using this formula:
%Alkaloid = (Final weight of extracts/Initial weight of
extracts) × 100
In vivo anti-inflammatory activity
Carrageenan-induced paw edema test
This test was carried out using carrageenan as a phlogistic
agent to induce paw edema in the right hind limb of
http://www.herbmedpharmacol.com
Cc − Ct
100
Cc
(1)
Here, Cc = Difference of paw circumference before and
after carrageenan injection for control group at different
time interval, Ct = Difference of paw circumference before
and after carrageenan injection for test group at different
time interval.
Formalin-induced paw edema test
The test was carried out using an established method
with minor modifications (17). Six groups of mice (five
mice to each group) were administered 1% tween-80 at
10 mL/kg, MDML and MDMS at the dose of 200 & 400
mg/kg orally and indomethacin at the dose of 10 mg/kg
intraperitoneally. One hour after the extracts and thirty
minutes after positive control administration, the mice
paw edema was induced by the subcutaneous injection of
50 μL of 2.5% formalin in 0.9% normal saline, into subplanar tissue of the paws of mice. The paw circumference
of mice was measured before and after formalin injection
at 1, 2, 3, and 4 hours by digital vernier calipers. Paw
edema was expressed as the change in paw circumference
(mm) by using the formula (1).
Xylene-induced ear edema test
Xylene-induced ear edema model permitted the
evaluation of anti-inflammatory steroids which was
conducted by using the previously described method
with slight modifications (18). Six groups of mice (five
mice to each group) were administered 1% tween-80 at
10 mL/kg, MDML and MDMS at the doses of 200 & 400
mg/kg orally and prednisolone at the dose of 10 mg/kg
intraperitoneally. Thirty minutes and fifteen minutes
after the oral treatment of extracts and positive control
administration to mice, respectively, the edema was
induced by applying 30 µL of xylene to the inner surface
of the right ear of mice using a syringe. Fifteen minutes
of post-xylene application, the animals were anesthetized
and both ears were cut off, sized, and weighed. The mean
difference of the weight between the right and left ears was
determined for each group and the percentage inhibition
of edema was calculated as following (19):
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
77
Afrin et al
Inhibition of edema (%) =
Wc − Wt
100
Wc
Here, Wc = Difference of ear weight in the negative control
group, Wt = Difference of ear weight in the test group
In vitro anti-arthritic activity
Preparation of solutions
To prepare 0.5 mL of each test solution, 0.45 mL of 0.5%
w/v aqueous solution of BSA was mixed with 0.05 mL of
MDML and MDMS of different concentrations (1000, 500,
250, 125, and 62.5 µg/mL). The pH of the test solutions
was adjusted to 6.3 using 1 N HCl.
To prepare 0.5 mL of standard solution, 0.45 mL of 0.5%
w/v aqueous solution of BSA was mixed with 0.05 mL
of diclofenac sodium of different concentrations (1000,
500, 250, 125, and 62.5 µg/mL). The pH of the standard
solutions was adjusted to 6.3 using 1 N HCl.
To prepare 0.5 mL of test control solution, 0.45 mL of
0.5% w/v aqueous solution of BSA was mixed with 0.05
mL of distilled water. The pH of the test control solutions
was adjusted to 6.3 using 1 N HCl.
To make 0.5 mL of product control solution, 0.05 mL
of test solution was mixed with 0.45 mL of distilled water.
The pH of the product control solutions was adjusted to
6.3 using 1 N HCl.
Distilled water was used as a blank to obtain the
absorbance by using UV-Vis spectroscopy.
Experiment design
The evaluation of in vitro anti-arthritic activities of MDML
and MDMS was conducted by using the “inhibition of
protein denaturation” method (20-22). In this method,
all the prepared solutions were incubated at 37°C for 20
minutes and then the temperature was increased to keep
the solutions at 57°C for 3 minutes. Then the solutions
were allowed to cool. After cooling, 2.5 mL of freshly
prepared phosphate buffer (pH 6.3) was added to the
previous solutions. The absorbance was measured by
using a UV-Visible spectrophotometer at 416 nm. The
percentage inhibition of BSA denaturation could be
calculated as:
A(t ) − A( pc)
% Inhibition = 100 −
100
A(tc )
Here, A(t)= Absorbance of test solution, A(pc)=
Absorbance of product control, A(tc)= Absorbance of test
control
Determination of median inhibitory concentration (IC50)
The relationship between concentration and inhibitory
effect of MDML and MDMS was expressed as a median
inhibitory concentration (IC50). This represented the
concentration of the sample required to inhibit 50% of
the protein denaturation after a certain exposure time and
determined by linear regression method from plotting
78
percentage of inhibition against the correspondent
logarithm of concentration. The concentration-inhibition
data were transformed into a straight line through a trend
line fit linear regression analysis (Microsoft Excel 2007);
the IC50 value was derived from the best-fit line obtained.
Statistical analysis
All the data were expressed as mean ± SEM (standard error
of mean). The results were analyzed statistically by oneway ANOVA followed by post hoc Dunnett’s t test using
statistical software Statistical Package for Social Science
(SPSS, Version 16.0, IBM Corporation, NY). Results
*P < 0.05, **P < 0.01 and ***P < 0.001 were considered
statistically significant as compared to control.
Results
Quantitative phytochemical screening
In the present study, it was found that MDML and MDMS
contained a considerable quantity of phenol, flavonoid,
and alkaloid. The current investigation showed that
total phenol content of MDML and MDMS was 15.67
± 1.5 and 23.56 ± 1.06 mg of gallic acid equivalent per
g of each of the extracts, respectively. Total flavonoid
content of MDML and MDMS was 11.8 ± 0.42 and 10.07
± 0.85 mg of Quercetin equivalent per g of each of the
extracts, respectively. Gallic acid and quercetin equivalent
concentration was obtained using the expression
from the calibration curve of gallic acid and quercetin
(Figure 1). The alkaloid content of MDML and MDMS
was determined to be 64.71 ± 0.94% and 59.24 ± 0.6%,
respectively (Table1).
In vivo anti-inflammatory activity
Carrageenan-induced paw edema test
In the current study of anti-inflammatory activity analysis
of the investigated extracts by using carrageenan-induced
paw edema test, negative control group showed the
increase in paw edema which extended up to 3 hours, and
then the paw edema was decreased slightly. Indomethacin,
positive control inhibited paw edema slightly and started
inhibiting paw edema from 3rd hour by 66.67% to 4th hour
by 73.53% significantly (P < 0.001). MDMS showed an
excellent effect in this method which inhibited paw edema
from 26.19% to 58.52% after its administration till the
4th hour at 200 mg/kg. MDMS increased the paw edema
inhibition at higher dose (400 mg/kg) which continued up
to 4th hour of its administration from 28.57% to 76.47%
significantly (P < 0.001) (Table 2).
Formalin-induced paw edema test
In formalin-induced paw edema test, negative control
group showed the increase in edema which slightly
decreased from the 3rd hour of the post-injection period,
whereas positive control group showed the inhibition of
paw edema from the 1st hour to the 4th hour of the post-
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
http://www.herbmedpharmacol.com
In vivo and in vitro pharmacological investigations of Macropanax dispermus (Araliaceae)
Callibration curve of Gallic Acid
Absorbance
2.5
Xylene-induced ear edema test
In xylene-induced ear edema test, negative control
group showed much increase in-ear edema whereas the
positive control, prednisolone reduced the edema by
81.66% during 15 minutes of post-injection significantly
(P < 0.001). MDML also showed an excellent potential to
reduce the edema by 74.62% at the low dose and 82.49% at
the high dose significantly (P < 0.001) (Table 4).
y = 0.0039x + 0.033
R² = 0.9987
2
Absorbance
1.5
1
Linear
(Absorbance)
0.5
0
0
500
1000
Concentration (µg/mL)
In vitro anti-arthritic activity
In the current study of in vitro anti-arthritic activity,
positive control showed much higher inhibition of protein
denaturation from 96.61% to 62.71% from the highest
concentration to the lowest concentration, whereas the
negative control did not show any inhibition of protein
denaturation. MDMS was observed to inhibit protein
denaturation effectively which was ranged from 61.02% to
0% (Table 5).
Absorbance
Callibration curve of Quercetin
y = 0.005x + 0.1192
R² = 0.8496
1.2
1
0.8
0.6
0.4
0.2
0
Absorbance
Linear
(Absorbance)
0
200
400
Concentration (µg/mL)
Discussion
From the ancient period, herbal medicines have been
used as the major therapy in medical practices. The
use of traditional medicine persists today because of its
medicinal value as well as a part of cultural beliefs in
many countries of the world and the toxicity and side
effects of conventional medicines (23). In this regard,
medicinal plant M. dispermus was investigated to discover
its potential as an effective anti-inflammatory and antiarthritic agent.
Figure 1. Calibration curve of gallic acid and quercetin.
injection period from 20.34% to 86.79%, significantly
(P < 0.001). In this study, MDMS also showed good effect
which demonstrated paw edema inhibition effect from
2nd hour significantly (P < 0.001) which was ranged from
24.59% to 50.94% (200 mg/kg) and 42.62% to 80.75% (400
mg/kg), respectively (Table 3).
Table 1. Total phenol, flavonoid, and alkaloid content of crude methanol extracts of M. dispermus leaves and stem barks
Total phenol mg/g of extracts (GAE)
Total flavonoid mg/g of extracts (QE)
Total Alkaloid content (%)
MDML (1 mg/mL)
15.67 ± 1.50
11.80 ± 0.42
64.71 ± 0.94
MDMS (1 mg/mL)
23.56 ± 1.06
10.07 ± 0.85
59.24 ± 0.60
Group
MDML, Crude methanol extracts of M. dispermus leaves; MDMS, Crude methanol extracts of M. dispermus stem barks; GAE, Gallic acid equivalent; QE, Quercetin equivalent.
Results were expressed as mean ± SEM.
Table 2. Anti-inflammatory activity of crude methanol extracts of M. dispermus leaves and stem barks by using carrageenan-induced paw edema test
Group
Dose (mg/kg)
Pre-injection paw
circumference (mm)
Post-injection paw circumference in mm (% of edema inhibition)
1h
2h
3h
4h
14.40 ± 0.51
14 ± 0.45
13.20 ± 0.37
13.60 ± 0.43
(26.09%)
14.20 ± 0.58
(6.52%)
12.90 ± 0.46
(41.30%)
13.70 ± 0.54
(26.09%)
13.10 ± 0.33
(45.65%)
11.60 ± 0.24**
(66.67%)
12.80 ± 0.58
(23.81%)
12.10 ± 0.60*
(54.76%)
12.60 ± 0.51
(45.24%)
11.90 ± 0.24*
(69.05%)
11.10 ± 0.33**
(73.53%)
11.80 ± 0.37*
(35.29%)
11.30 ± 0.44**
(67.65%)
11.70 ± 0.34*
(58.52%)
11.40 ± 0.19**
(76.47%)
Control
10 mL/kg
9.80 ± 0.58
14 ± 0.45
Indomethacin
10
10.20 ± 0.37
13 ± 0.32 (33.33%)
200
9.60 ± 0.24
400
10.20 ± 0.37
200
10.30 ± 0.3
400
10.60 ± 0.24
MDML
MDMS
12.80 ± 0.37
(23.81%)
13.20 ± 0.58
(28.57%)
13.40 ± 0.4
(26.19%)
13.60 ± 0.24
(28.57%)
MDML, Crude methanol extracts of M. dispermus leaves; MDMS, Crude methanol extracts of M. dispermus stem barks.
Results were expressed as mean ± SEM.
Results were significant at *P < 0.05, **P < 0.01 and ***P < 0.001 as compared to negative control group.
http://www.herbmedpharmacol.com
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
79
Afrin et al
Table 3. Anti-inflammatory activity of crude methanol extracts of M. dispermus leaves and stem barks by using formalin-induced paw edema test
Post-injection mean paw circumference (mm) (% of edema inhibition)
Group
Dose (mg/
kg)
Pre-injection paw
circumference (mm)
1h
2h
3h
4h
Control
10 mL/kg
10.60 ± 0.24
16.50 ± 0.22
16.70 ± 0.2
16.10 ± 0.24
15.90 ± 0.19
Indomethacin
10
10.30 ± 0.3
15 ± 0.32*
(20.34%)
13.10 ± 0.24***
(54.1%)
11.60 ± 0.19***
(76.36%)
11 ± 0.27***
(86.79%)
200
10.20 ± 0.34
16 ± 0.45 (1.69%)
14.90 ± 0.4**
(22.95%)
13.90 ± 0.48***
(32.73%)
13.30 ± 0.49***
(41.51%)
400
10.40 ± 0.24
15.30 ± 0.44
(16.95%)
13.60 ± 0.37***
(47.54%)
12.70 ± 0.20***
(58.18%)
11.60 ± 0.24***
(77.37%)
200
10.80 ± 0.37
16.40 ± 0.29
(5.08%)
15.40 ± 0.19*
(24.59%)
14.30 ± 0.30**
(36.36%)
13.40 ± 0.37***
(50.94%)
400
10.40 ± 0.24
15.70 ± 0.41
(10.17%)
13.90 ± 0.33***
(42.62%)
12.20 ± 0.34***
(67.27%)
11.42 ± 0.28***
(80.75%)
MDML
MDMS
MDML, Crude methanol extracts of M. dispermus leaves; MDMS, Crude methanol extracts of M. dispermus stem barks.
Results were expressed as mean ± SEM.
Results were significant at *P < 0.05, **P < 0.01 and ***P < 0.001 as compared to negative control group.
Table 4. Anti-inflammatory activity of crude methanol extracts of M. dispermus leaves and stem barks by using xylene-induced ear edema test
Mean difference in ear weight
Inhibition of edema (%)
Group
Dose (mg/kg)
Control
10 mL/kg
45.80 ± 3.08
-
10
8.40 ± 1.50***
81.66
200
11.62 ± 0.50***
74.62
400
8.02 ± 0.58***
82.49
200
15.32 ± 3.23***
66.55
400
8.83 ± 1.42***
80.73
Prednisolone
MDML
MDMS
MDML, Crude methanol extracts of M. dispermus leaves; MDMS, Crude methanol extracts of M. dispermus stem barks; GAE, Gallic acid equivalent; QE, Quercetin equivalent.
Results were expressed as mean ± SEM.
Results were significant at *P < 0.05, **P < 0.01 and ***P < 0.001 as compared to negative control group.
Table 5. Anti-arthritic activity of crude methanol extracts of M. dispermus leaves (MDML) and stem barks (MDMS)
Group
Control
Diclofenac Sodium
MDML
MDMS
Concentration (µg/mL)
1000
500
250
125
62.5
1000
500
250
125
62.5
1000
500
250
125
62.5
% of Inhibition of Protein Denaturation
0
96.61
91.53
81.36
74.58
62.71
45.76
33.90
28.81
20.34
3.39
61.02
45.76
30.51
1.69
0
IC50 (µg/mL)
-
19.26
1317.51
631.59
MDML, Crude methanol extracts of M. dispermus leaves; MDMS, Crude methanol extracts of M. dispermus stem barks.
In carrageenan-induced paw edema model, negative
control did not show any inhibition of paw edema, whereas
indomethacin inhibited the paw edema significantly from
the 3rd hour. When compared to negative control group,
MDML showed inhibition of paw edema from the 3rd hour
at low dose and from the 1st hour at high dose. Its low
80
dose possessed mild effect whereas its high dose showed
significant and high potential as an anti-inflammatory
agent. MDMS showed significant inhibition of paw
edema from the 1st hour which continued up to 4th hour as
compared to negative control group. It showed a moderate
anti-inflammatory effect at a low dose, and its higher dose
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
http://www.herbmedpharmacol.com
In vivo and in vitro pharmacological investigations of Macropanax dispermus (Araliaceae)
showed an excellent anti-inflammatory as well as an antiedematogenic effect. The anti-inflammatory mechanism
of MDML and MDMS might be related to the inhibition
of prostaglandins and nitric oxide synthesis, as described
for the anti-inflammatory mechanism of indomethacin
in inhibiting the inflammatory process, induced by
carrageenan (24).
In formalin-induced paw edema test, negative control
group showed no inhibition, whereas indomethacin
showed the inhibition slightly at the first two hours of
post-injection which was predominant during the last
two hours of post-injection period significantly. When
compared to negative control group, MDML showed
significant inhibition of formalin-induced paw edema at
both doses from the 2nd hour of post-injection. MDML
showed a moderate anti-inflammatory effect at the low
dose (200 mg/kg) which showed high potential to inhibit
the inflammatory edema at the high dose (400 mg/kg).
When compared to negative control group, MDMS also
displayed significant inhibition of formalin-induced paw
edema from the 2nd hour of post-injection of formalin.
MDMS at the low dose showed moderate and at the high
dose, it exhibited excellent anti-inflammatory activity up
to 4th hour of the post-injection period. This indicated
that it had a strong inhibitory effect on the proliferation of
fibroblasts and also probably connective tissue modulation
effect. But, it did not reflect a good neurogenic effect in
the reduction of formalin-induced inflammation.
In xylene-induced ear edema test, negative control
group asserted much increase in the ear edema whereas
prednisolone showed the highest inhibition of ear edema,
since it acted as a steroid agent to inhibit the production
of phospholipase A2 (25).. It was quite evident that it would
reduce the xylene-induced neurogenic inflammation
successfully. When compared to negative control group,
MDML and MDMS showed an excellent potential to
decrease the xylene-induced ear edema at both doses
significantly (P < 0.001). MDML at the high dose (400 mg/
kg) showed more effectiveness in decreasing ear edema
than that of positive control group and proved that it
might be an excellent alternative of prednisolone. MDMS
also could be used as a highly active anti-inflammatory
agent at the higher dose.
In the current study of anti-arthritic activity, diclofenac
sodium was used as a reference standard which is used
conventionally as an anti-arthritic agent. It showed the
highest inhibition of thermally induced denaturation of
BSA at the highest concentration of 1000 µg/mL. It showed
a decrease in the inhibition of protein denaturation with
the decreasing concentration. MDML showed a very mild
and concentration-dependent effect as an antiarthritic
agent with comparison to control and standard. MDMS
also showed less inhibition of BSA denaturation than
that of standard solution at the lowest concentration.
When compared to control and standard, MDMS showed
http://www.herbmedpharmacol.com
moderate effectiveness as an anti-arthritic agent at a higher
concentration. Considering the IC50 value, MDMS was
evident as more as a potent herbal remedy for arthritis.
The findings of the present study did not associate
albumin denaturation in the inflammatory process, but
there might be a relevant connection to studies made on
the antigenicity of albumin aggregates (26).
Previous studies reported that some plants that were rich
in alkaloids and flavonoids, showed anti-inflammatory
as well as anti-arthritic activity (27-29). In the current
research, quantitative analysis showed a considerable and
different amount of phenols, flavonoids, and a higher
percentage of alkaloids in MDML and MDMS. The
presence of those phytoconstituents might contribute to
their different pharmacological activities.
Conclusion
MDML and MDMS contains a considerable amount of
phenols, flavonoids, and alkaloids and are excellent antiinflammatory and anti-arthritic agents. This research
work can help formulate a potent herbal entity that may
be used in the treatment of inflammation and arthritis.
Further research must be conducted to isolate and identify
its active compounds which will surely be responsible for
their pharmacological activities.
Acknowledgements
This study was a part of the thesis for the degree of
Master in Pharmacy. We would like to acknowledge the
financial support of the study by the Ministry of Science
and Technology, Govt. of Peoples’ Republic of Bangladesh.
Authors are thankful to the Pharmacy Department,
University of Chittagong for the earnest co-operation
by providing laboratory support to carry out the whole
study. We are also thankful to Pharmacy Department
of Jahangirnagar University for their generous supply of
mice. The authors would like to thank Professor Dr. Shaikh
Bokhtear Uddin, Department of Botany, University of
Chittagong for the identification of the plant.
Author’s contributions
MKH designed the research experiment and conception.
SRA collected and processed the plant material. SRA and
MKS carried out the laboratory work. Data analysis and
interpretation were aided by the MRI and SA. NMP and
MRI made the necessary corrections in the write up and
critically revised the manuscript, gave final approval for
the submission of revised version. Finally, all authors read
the final version and gave their consent to submit.
Conflict of interests
All authors declare that they have no competing interest.
Ethical considerations
All authors hereby declare that “Principle of laboratory
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
81
Afrin et al
animal care” (NIH publication No. 85-23, revised 1985)
were followed, as well as specific national laws where
applicable. All proposed research protocols have been
examined and approved by the ethical committee of
University of Chittagong, Bangladesh under the approval
no- cc98056.
Funding/Support
This study was financially supported by the Ministry of
Science and Technology, Govt. of Peoples’ Republic of
Bangladesh (Grant No. BS-312). Pharmacy Department,
University of Chittagong provided the necessary
laboratory equipments.
References
1.
Schmid-Schönbein GW. Analysis of inflammation. Annu
Rev Biomed Eng. 2006;8:93-131. doi: 10.1146/annurev.
bioeng.8.061505.095708.
2. Soysal P, Arik F, Smith L, Jackson SE, Isik AT.
Inflammation, Frailty and Cardiovascular Disease.
Adv
Exp Med Biol. 2020;1216:55-64. doi: 10.1007/978-3-03033330-0_7.
3. Umapathy E, Ndebia E, Meeme A, Adam B, Menziwa P,
Nkeh-Chungag B, et al. An experimental evaluation of
Albuca setosa aqueous extract on membrane stabilization,
protein denaturation and white blood cell migration during
acute inflammation. J Med Plants Res. 2010;4(9):789-95.
doi: 10.5897/jmpr10.056.
4. Gorzalczany S, López P, Acevedo C, Ferraro G. Antiinflammatory effect of Lithrea molleoides extracts
and isolated active compounds. J Ethnopharmacol.
2011;133(3):994-8.
doi:
10.1016/j.jep.2010.11.031.
5. Baranwal VK, Irchhaiya R, Alok S. Anti-arthritic activity
of some indigenous plants: a review. Int J Pharm Sci Res.
2012;3(4):981-86.
6. Iffath Hina M, Caroline Rose J. In vitro anti-inflammatory
and antiarthritic activity of Pergularia daemia leaves and
roots. Int J Drug Dev Res. 2018;10(1):10-3.
7. Nimesh S. Herbal drug is better than allopathic drug in
the treatment of Rheumatoid arthritis. Int J Pharmacogn.
2018;5(9):539-45.
8. Patil KR, Patil CR, Jadhav RB, Mahajan VK, Patil PR,
Gaikwad PS. Anti-arthritic activity of bartogenic acid
isolated from fruits of Barringtonia racemosa Roxb.
(Lecythidaceae). Evid Based Complement Alternat Med.
2011;2011:785245. doi: 10.1093/ecam/nep148.
9. Panyaphu K, On TV, Sirisa-ard P, Srisa-nga P, ChansaKaow
S, Nathakarnkitkul S. Medicinal plants of the Mien (Yao) in
Northern Thailand and their potential value in the primary
healthcare of postpartum women. J Ethnopharmacol.
2011;135(2):226-37. doi: 10.1016/j.jep.2011.03.050.
10. Ong HG, Ling SM, Win TTM, Kang D-H, Lee J-H, Kim
Y-D. Ethnobotany of wild medicinal plants used by the
Müün ethnic people: a quantitative survey in southern Chin
state, Myanmar. J Herb Med. 2018;13:91-6. doi: 10.1016/j.
hermed.2017.09.006.
11. Chanwitheesuk A, Teerawutgulrag A, Rakariyatham
N. Screening of antioxidant activity and antioxidant
compounds of some edible plants of Thailand. Food Chem.
82
2005;92(3):491-7. doi: 10.1016/j.foodchem.2004.07.035.
12. Islam MR, Naima J, Proma NM, Hussain MS, Uddin
SMN, Hossain MK. In-vivo and in-vitro evaluation of
pharmacological activities of Ardisia solanacea leaf extract.
Clin Phytosci. 2019;5(1):32. doi: 10.1186/s40816-019-01289.
13. Roby MHH, Sarhan MA, Selim KA-H, Khalel KI.
Evaluation of antioxidant activity, total phenols and
phenolic compounds in thyme (Thymus vulgaris L.), sage
(Salvia officinalis L.), and marjoram (Origanum majorana
L.) extracts. Ind Crops Prod. 2013;43:827-31. doi: 10.1016/j.
indcrop.2012.08.029.
14. Velásquez P, Montenegro G, Leyton F, Ascar L, Ramirez
O, Giordano A. Bioactive compounds and antibacterial
properties of monofloral Ulmo honey. CYTA J Food.
2020;18(1):11-9. doi: 10.1080/19476337.2019.1701559.
15. Sreedevi P, Vijayalakshmi K, Venkateswari R.
Phytochemical evaluation of Punica granatum L. leaf
extract. Int J Curr Pharm Res. 2017;9(4):14-8. doi: 10.22159/
ijcpr.2017v9i4.1159.
16. Rege MG, Ayanwuyi LO, Zezi AU, Odoma S. Antinociceptive, anti-inflammatory and possible mechanism
of anti-nociceptive action of methanol leaf extract of
Nymphaea lotus Linn (Nymphaeceae). J Tradit Complement
Med. 2020. doi: 10.1016/j.jtcme.2020.02.010.
17. Seddighfar M, Mirghazanfari SM, Dadpay M. Analgesic and
anti-inflammatory properties of hydroalcoholic extracts of
Malva sylvestris, Carum carvi or Medicago sativa, and their
combination in a rat model. J Integr Med. 2020;18(2):181-8.
doi: 10.1016/j.joim.2020.02.003.
18. Karim N, Khan I, Khan W, Khan I, Khan A, Halim SA,
et al. Anti-nociceptive and anti-inflammatory activities
of Asparacosin A involve selective cyclooxygenase 2 and
inflammatory cytokines inhibition: an in-vitro, in-vivo,
and in-silico approach. Front Immunol. 2019;10:581. doi:
10.3389/fimmu.2019.00581.
19. Akindele AJ, Adeyemi OO. Antiinflammatory activity of the
aqueous leaf extract of Byrsocarpus coccineus. Fitoterapia.
2007;78(1):25-8. doi: 10.1016/j.fitote.2006.09.002.
20. Mishra N, Bstia S, Mishra G, Chowdary K, Patra S. Antiarthritic activity of Glycyrrhiza glabra, Boswellia serrata and
their synergistic activity in combined formulation studied
in freund’s adjuvant induced arthritic rats. J Pharm Educ
Res. 2011;2(2):92-8.
21. Singh M, Soni P, Upmanyu N, Shivhare Y. In-vitro antiarthritic activity of Manilkara zapota Linn. Asian J Pharma
Technol. 2011;1(4):123-24.
22. Volluri SS, Bammidi SR, Chippada SC, Vangalapati M. Invitro anti-arthritic activity of methanolic extract of Bacopa
monniera. Int J Chem Environ Pharm Res. 2011;2(2-3):1569.
23. Verma S, Singh SP. Current and future status of herbal
medicine. Vet World. 2008;1(11):347-50. doi: 10.5455/
vetworld.2008.347-350.
24. Jayasuriya W, Handunnetti SM, Wanigatunge CA, Fernando
GH, Abeytunga DTU, Suresh TS. Anti-inflammatory
activity of Pleurotus ostreatus, a culinary medicinal
mushroom, in wistar rats. Evid Based Complement Alternat
Med. 2020;2020:6845383. doi: 10.1155/2020/6845383.
25. Adeyemi OO, Yemitan OK, Afolabi L. Inhibition of
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
http://www.herbmedpharmacol.com
In vivo and in vitro pharmacological investigations of Macropanax dispermus (Araliaceae)
chemically induced inflammation and pain by orally and
topically administered leaf extract of Manihot esculenta
Crantz in rodents. J Ethnopharmacol. 2008;119(1):6-11.
doi: 10.1016/j.jep.2008.05.019.
26. Elisha IL, Dzoyem JP, McGaw LJ, Botha FS, Eloff JN. The
anti-arthritic, anti-inflammatory, antioxidant activity and
relationships with total phenolics and total flavonoids
of nine South African plants used traditionally to treat
arthritis. BMC Complement Altern Med. 2016;16(1):307.
doi: 10.1186/s12906-016-1301-z.
27. Shu H, Arita H, Hayashida M, Sekiyama H, Hanaoka
http://www.herbmedpharmacol.com
K. Effects of processed Aconiti tuber and its ingredient
alkaloids on the development of antinociceptive tolerance
to morphine. J Ethnopharmacol. 2006;103(3):398-405. doi:
10.1016/j.jep.2005.08.017.
28. Dimo T, Fotio AL, Nguelefack TB, Asongalem EA,
Kamtchouing P. Antiinflammatory activity of leaf
extracts of Kalanchoe crenata Andr. Indian J Pharmacol.
2006;38(2):115-9.
doi:
10.4103/0253-7613.24617.
29. Borgi W, Ghedira K, Chouchane N. Antiinflammatory and
analgesic activities of Zizyphus lotus root barks. Fitoterapia.
2007;78(1):16-9. doi: 10.1016/j.fitote.2006.09.010.
Journal of Herbmed Pharmacology, Volume 10, Number 1, January 2021
83